MMP9 and lung carcinoma: The genotype frequencies for the MMP-9-1562C/T polymorphism in lung cancer patients were CC 67.9%, CT 26.8%, and TT 2.7%, and CC 70.0%, CT 25.0%, and TT 4.0% in the control group, respectively, with no statistically significant differences observed between these two groups.